Search Results - "MESH: Genetic Predisposition to Disease"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Contributors: Darst, Burcu Shen, Jiayi Madduri, Ravi et al.

    Source: Darst, B F, Shen, J, Madduri, R K, Rodriguez, A A, Xiao, Y, Sheng, X, Saunders, E J, Dadaev, T, Brook, M N, Hoffmann, T J, Muir, K, Wan, P, Le Marchand, L, Wilkens, L, Wang, Y, Schleutker, J, MacInnis, R J, Cybulski, C, Neal, D E, Nordestgaard, B G, Nielsen, S F, Batra, J, Clements, J A, Cancer BioResource, A P, Grönberg, H, Pashayan, N, Travis, R C, Park, J Y, Albanes, D, Weinstein, S, Mucci, L A, Hunter, D J, Penney, K L, Tangen, C M, Hamilton, R J, Parent, M-É, Stanford, J L, Koutros, S, Wolk, A, Sørensen, K D, Blot, W J, Yeboah, E D, Mensah, J E, Lu, Y-J, Schaid, D J, Thibodeau, S N, West, C M, Maier, C, Kibel, A S, Cancel-Tassin, G & NC-LA PCaP Investigators 2023, ' Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry ', American Journal of Human Genetics, vol. 110, no. 7, pp. 1200-1206 . https://doi.org/10.1016/j.ajhg.2023.05.010

    File Description: application/pdf

  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Source: Genet Med
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    Dipòsit Digital de la UB
    Universidad de Barcelona
    Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
    instname
    Scientia
    Scientia. Dipòsit d'Informació Digital del Departament de Salut
    HEBON Investigators, KConFab Investigators, GEMO Study Collaborators, EMBRACE Collaborators & OCGN Investigators 2021, 'The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant', Genetics in Medicine, vol. 23, no. 9, pp. 1726-1737. https://doi.org/10.1038/s41436-021-01198-7
    Genetics in Medicine, 23, 9, pp. 1726-1737
    Lakeman, I M M, van den Broek, A J, Vos, J A M, Barnes, D R, Adlard, J, Andrulis, I L, Arason, A, Arnold, N, Arun, B K, Balmaña, J, Barrowdale, D, Benitez, J, Borg, A, Caldés, T, Caligo, M A, Chung, W K, Claes, K B M, Barouk-Simonet, E, Belotti, M, Berthet, P, Bignon, Y J, Bonadona, V, Bressac-de Paillerets, B, Buecher, B, Caputo, S, Caron, O, Castera, L, Caux-Moncoutier, V, Colas, C, Collonge-Rame, M A, Coupier, I, de Pauw, A, Delnatte, C, Elan, C, Faivre, L, Ferrer, S F, Gauthier-Villars, M, Gesta, P, Giraud, S, Golmard, L, Houdayer, C, Lasset, C, Laurent, M, Leroux, D, Longy, M, Mari, V, Mazoyer, S, Mebirouk, N, Mortemousque, I, Jensen, U B, GEMO Study Collaborators, EMBRACE Collaborators, OCGN Investigators, HEBON Investigators & KConFab Investigators 2021, 'The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant', Genetics in Medicine, vol. 23, no. 9, pp. 1726-1737. https://doi.org/10.1038/s41436-021-01198-7
    Lakeman, I M M, van den Broek, A J, Vos, J A M, Barnes, D R, Adlard, J, Andrulis, I L, Arason, A, Arnold, N, Arun, B K, Balmaña, J, Barrowdale, D, Benitez, J, Borg, A, Caldés, T, Caligo, M A, Chung, W K, Claes, K B M, Barouk-Simonet, E, Belotti, M, Berthet, P, Bignon, Y J, Bonadona, V, Bressac-de Paillerets, B, Buecher, B, Caputo, S, Caron, O, Castera, L, Caux-Moncoutier, V, Colas, C, Collonge-Rame, M A, Coupier, I, de Pauw, A, Delnatte, C, Elan, C, Faivre, L, Ferrer, S F, Gauthier-Villars, M, Gesta, P, Giraud, S, Golmard, L, Houdayer, C, Lasset, C, Laurent, M, Leroux, D, Longy, M, Mari, V, Mazoyer, S, Mebirouk, N, Mortemousque, I, Gerdes, A M, GEMO Study Collaborators, EMBRACE Collaborators, OCGN Investigators, HEBON Investigators & kConFab Investigators 2021, ' The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant ', Genetics in Medicine, vol. 23, no. 9, pp. 1726-1737 . https://doi.org/10.1038/s41436-021-01198-7
    Lakeman, I M M, van den Broek, A J, Vos, J A M, Barnes, D R, Adlard, J, Andrulis, I L, Arason, A, Arnold, N, Arun, B K, Balmaña, J, Barrowdale, D, Benitez, J, Borg, A, Caldés, T, Caligo, M A, Chung, W K, Claes, K B M, Barouk-Simonet, E, Belotti, M, Berthet, P, Bignon, Y J, Bonadona, V, Bressac-de Paillerets, B, Buecher, B, Caputo, S, Caron, O, Castera, L, Caux-Moncoutier, V, Colas, C, Collonge-Rame, M A, Coupier, I, de Pauw, A, Delnatte, C, Elan, C, Faivre, L, Ferrer, S F, Gauthier-Villars, M, Gesta, P, Giraud, S, Golmard, L, Houdayer, C, Lasset, C, Laurent, M, Leroux, D, Longy, M, Mari, V, Mazoyer, S, Mebirouk, N, Gerdes, A M, Jensen, U B, Thomassen, M, GEMO Study Collaborators, EMBRACE Collaborators, OCGN Investigators, HEBON Investigators & kConFab Investigators 2021, ' The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant ', Genetics in Medicine, vol. 23, no. 9, pp. 1726-1737 . https://doi.org/10.1038/s41436-021-01198-7
    Lakeman, IMM, van, D B AJ, Vos, JAM, Barnes, DR, Adlard, J, Andrulis, IL, Arason, A, Arnold, N, Arun, BK, Balmaña, J, Barrowdale, D, Benitez, J, Borg, A, Schmidt, MK & Evans, D G 2021, 'The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.', Genetics in medicine : official journal of the American College of Medical Genetics, vol. 23, no. 9, pp. 1726-1737. https://doi.org/10.1038/s41436-021-01198-7
    Genetics in Medicine, vol 23, iss 9
    GENETICS IN MEDICINE

    Subject Terms: SUSCEPTIBILITY ALLELES, Diàtesi, FAMILIES, MESH: BRCA2 Protein, Breast cancer, 0302 clinical medicine, MESH: Risk Factors, KconFab Investigators, Otros calificadores::Otros calificadores::/diagnóstico, Risk Factors, Medicine and Health Sciences, 2.1 Biological and endogenous factors, Mama - Càncer - Diagnòstic, MESH: Heterozygote, Cancer, HEBON Investigators, Genetics & Heredity, Factors de risc en les malalties, BRCA1 Protein, MESH: Genetic Predisposition to Disease, article, Biological Sciences, OVARIAN, BRCA2 Protein/genetics, DISEASES::Pathological Conditions, Signs and Symptoms::Pathologic Processes::Disease Attributes::Disease Susceptibility::Genetic Predisposition to Disease, 3. Good health, OCGN Investigators, Female, Malalties congènites, Adult, Heterozygote, MESH: Mutation, Polygenic risk score (PRS313), Risk factors in diseases, Clinical Sciences, Radboudumc 17: Women's cancers RIHS: Radboud Institute for Health Sciences, Breast Neoplasms, MUTATION CARRIERS, [SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics, Article, Other subheadings::Other subheadings::/diagnosis, Càncer de mama, GEMO Study Collaborators, 03 medical and health sciences, Contralateral breast cancer (CBC), SDG 3 - Good Health and Well-being, Breast Cancer, Genetics, Humans, Women, Genetic Predisposition to Disease, EMBRACE Collaborators, MESH: BRCA1 Protein, Retrospective Studies, BRCA2 Protein, MESH: Humans, ENFERMEDADES::afecciones patológicas, signos y síntomas::procesos patológicos::atributos de la enfermedad::susceptibilidad a enfermedades::predisposición genética a la enfermedad, Prevention, CONSORTIUM, Breast Neoplasms/diagnosis, MESH: Adult, MESH: Retrospective Studies, BRCA1, Radboudumc 14: Tumours of the digestive tract RIHS: Radboud Institute for Health Sciences, BRCA2, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, Mutation, Women's Health, BRCA1 Protein/genetics, Human Genetics - Radboud University Medical Center, MESH: Female, ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias de la mama, MESH: Breast Neoplasms, DISEASES::Neoplasms::Neoplasms by Site::Breast Neoplasms

    File Description: application/pdf; application/zip; text/xml; text; Print-Electronic

    Access URL: https://www.nature.com/articles/s41436-021-01198-7.pdf
    https://pubmed.ncbi.nlm.nih.gov/34113011
    https://hdl.handle.net/20.500.12530/84585
    http://hdl.handle.net/2445/178786
    https://hdl.handle.net/2445/178786
    https://hdl.handle.net/11351/7091
    https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/244113
    https://pubmed.ncbi.nlm.nih.gov/34113011/
    https://www.repository.cam.ac.uk/handle/1810/324949
    https://www.hirsla.lsh.is/handle/2336/621933
    https://www.narcis.nl/publication/RecordID/oai%3Ascholarlypublications.universiteitleiden.nl%3Aitem_3213874
    https://escholarship.org/uc/item/9c71h04q
    https://researchportal.helsinki.fi/en/publications/the-predictive-ability-of-the-313-variant-based-polygenic-risk-sc
    https://research.vumc.nl/en/publications/ccb2286d-7fdc-46b2-bc0b-425531bb3071
    https://hdl.handle.net/1887/3213874
    https://repository.ubn.ru.nl//bitstream/handle/2066/244113/244113.pdf
    https://hdl.handle.net/2066/244113
    https://pure.au.dk/ws/files/273850034/1_s2.0_S1098360021051017_main.pdf
    https://curis.ku.dk/ws/files/302065928/1_s2.0_S1098360021051017_main.pdf
    https://findresearcher.sdu.dk:8443/ws/files/192574540/s41436_021_01198_7.pdf
    https://escholarship.org/content/qt9c71h04q/qt9c71h04q.pdf
    https://escholarship.org/uc/item/9c71h04q
    http://doi.org/10.1038/s41436-021-01198-7
    https://biblio.ugent.be/publication/8715573
    https://biblio.ugent.be/publication/8715573/file/8715577
    http://hdl.handle.net/1854/LU-8715573
    https://eprints.soton.ac.uk/452125/
    https://pure.au.dk/ws/files/273850034/1_s2.0_S1098360021051017_main.pdf
    https://doi.org/10.1038/s41436-021-01198-7
    http://www.scopus.com/inward/record.url?scp=85115935642&partnerID=8YFLogxK
    https://pure.au.dk/portal/en/publications/4b86801e-70a5-4702-b255-c348515c7734

  15. 15

    Contributors: Alice Lannes Eric Bui Catherine Arnaud et al.

    Source: Psychological Medicine. 51:2321-2336

  16. 16

    Source: Prostate Cancer Prostatic Dis
    Huynh-Le, M-P, Karunamuni, R, Fan, C C, Asona, L, Thompson, W K, Martinez, M E, Eeles, R A, Kote-Jarai, Z, Muir, K R, Lophatananon, A, Schleutker, J, Pashayan, N, Batra, J, Grönberg, H, Neal, D E, Nordestgaard, B G, Tangen, C M, MacInnis, R J, Wolk, A, Albanes, D, Haiman, C A, Travis, R C, Blot, W J, Stanford, J L, Mucci, L A, West, C M L, Nielsen, S F, Kibel, A S, Cussenot, O, Berndt, S I, Koutros, S, Sørensen, K D, Cybulski, C, Grindedal, E M, Menegaux, F, Park, J Y, Ingles, S A, Maier, C, Hamilton, R J, Rosenstein, B S, Lu, Y-J, Watya, S, Vega, A, Kogevinas, M, Wiklund, F, Penney, K L, Huff, C D, Teixeira, M R, Multigner, L, Leach, R J & UKGPCS collaborators 2022, 'Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score', Prostate Cancer and Prostatic Diseases, vol. 25, no. 4, pp. 755-761. https://doi.org/10.1038/s41391-022-00497-7
    Minh-Phuong Huynh-Le, Karunamuni, R, Fan, C C, Asona, L, Thompson, W K, Martinez, M E, Eeles, R A, Kote-Jarai, Z, Muir, K R, Lophatananon, A, Schleutker, J, Pashayan, N, Batra, J, Groenberg, H, Neal, D E, Nordestgaard, B G, Tangen, C M, MacInnis, R J, Wolk, A, Albanes, D, Haiman, C A, Travis, R C, Blot, W J, Stanford, J L, Mucci, L A, West, C M L, Nielsen, S F, Kibel, A S, Cussenot, O, Berndt, S, Koutros, S, Sorensen, K D, Cybulski, C, Grindedal, E M, Menegaux, F, Park, J Y, Ingles, S A, Maier, C, Hamilton, R J, Rosenstein, B S, Lu, Y-J, Watya, S, Vega, A, Kogevinas, M, Wiklund, F, Penney, K L, Huff, C D, Teixeira, M R, Multigner, L, Leach, R J, UKGPCS Collaborators, APCB Australian Prostate Canc BioR, NC-LA PCaP Investigators, IMPACT Study Steering Comm Collabo, Canary PASS Investigators, Profile Study Steering Comm & PRACTICAL consortium 2022, ' Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score ', Prostate Cancer and Prostatic Diseases, vol. 25, pp. 755–761 . https://doi.org/10.1038/s41391-022-00497-7
    UKGPCS Collaborators 2022, 'Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-022-00497-7
    Prostate Cancer and Prostatic Diseases, vol 25, iss 4
    PROSTATE CANCER AND PROSTATIC DISEASES

    Subject Terms: SELECTION, Male, 0301 basic medicine, Aging, [SDV]Life Sciences [q-bio], Clinical sciences, LASSO, MESH: Risk Assessment, UKGPCS collaborators, 0302 clinical medicine, MESH: Risk Factors, Risk Factors, multi-ancestry datasets, Medicine and Health Sciences, PRACTICAL Consortium, Minority Health, Precision Medicine, 10. No inequality, Cancer genetics, Early Detection of Cancer, Cancer, Prostatic Neoplasms/diagnosis, 0303 health sciences, Manchester Cancer Research Centre, Prostate Cancer, MESH: Genetic Predisposition to Disease, APCB, Single Nucleotide, Urology & Nephrology, Prostate-Specific Antigen/genetics, prostate cancer, MESH: Prostate-Specific Antigen, 3. Good health, Health Disparities, [SDV] Life Sciences [q-bio], Oncology, Life Sciences & Biomedicine, Urologic Diseases, Clinical Sciences, Oncology and Carcinogenesis, The Profile Study Steering Committee, Polymorphism, Single Nucleotide, Risk Assessment, Article, Cancer screening, APCB (Australian Prostate Cancer BioResource), 03 medical and health sciences, Cancer epidemiology, SDG 3 - Good Health and Well-being, NC-LA PCaP Investigators, 3211 Oncology and carcinogenesis, Genetics, MESH: Early Detection of Cancer, Humans, 1112 Oncology and Carcinogenesis, Genetic Predisposition to Disease, Polymorphism, MESH: Polymorphism, Cancer och onkologi, Canary PASS Investigators, MESH: Humans, Science & Technology, Biomedical and Clinical Sciences, IMPACT Study Steering Committee and Collaborators, RC0254 Neoplasms. Tumors. Oncology (including Cancer), Profile Study Steering Committee, Prevention, 3202 Clinical sciences, Prostatic Neoplasms, Oncology and carcinogenesis, Prostate-Specific Antigen, MESH: Male, ResearchInstitutes_Networks_Beacons/mcrc, name=Manchester Cancer Research Centre, Good Health and Well Being, MESH: Prostatic Neoplasms, Cancer and Oncology, The PRACTICAL Consortium, The IMPACT Study Steering Committee and Collaborators

    File Description: application/pdf; text/xml; Print-Electronic

  17. 17

    Source: American Journal of Medical Genetics Part A. 185:3057-3061

    File Description: application/pdf

  18. 18

    Source: Dias, C, Pfundt, R, Kleefstra, T, Shuurs-Hoeijmakers, J, Boon, E M J, van Hagen, J M, Zwijnenburg, P, Weiss, M M, Keren, B, Mignot, C, Isapof, A, Weiss, K, Hershkovitz, T, Iascone, M, Maitz, S, Feichtinger, R G, Kotzot, D, Mayr, J A, Ben-Omran, T, Mahmoud, L, Pais, L S, Walsh, C A, Shashi, V, Sullivan, J A, Stong, N, Lecoquierre, F, Guerrot, A M, Charollais, A & Rodan, L H 2021, 'De novo variants in TCF7L2 are associated with a syndromic neurodevelopmental disorder', American Journal of Medical Genetics, Part A, vol. 185, no. 8, pp. 2384-2390. https://doi.org/10.1002/ajmg.a.62254
    American Journal of Medical Genetics. Part A, 185, 8, pp. 2384-2390

  19. 19

    Source: Nat Genet
    Nature genetics 53(6), 787-793 (2021). doi:10.1038/s41588-021-00847-6

    File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

  20. 20